These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1578 related items for PubMed ID: 9876338

  • 21. Sex-specific effects of dehydroepiandrosterone (DHEA) on bone mineral density and body composition: A pooled analysis of four clinical trials.
    Jankowski CM, Wolfe P, Schmiege SJ, Nair KS, Khosla S, Jensen M, von Muhlen D, Laughlin GA, Kritz-Silverstein D, Bergstrom J, Bettencourt R, Weiss EP, Villareal DT, Kohrt WM.
    Clin Endocrinol (Oxf); 2019 Feb; 90(2):293-300. PubMed ID: 30421439
    [Abstract] [Full Text] [Related]

  • 22. Relationships between dehydroepiandrosterone-sulphate and anthropometric, metabolic and hormonal variables in a large cohort of obese women.
    Maccario M, Mazza E, Ramunni J, Oleandri SE, Savio P, Grottoli S, Rossetto R, Procopio M, Gauna C, Ghigo E.
    Clin Endocrinol (Oxf); 1999 May; 50(5):595-600. PubMed ID: 10468925
    [Abstract] [Full Text] [Related]

  • 23. Low dose dehydroepiandrosterone affects behavior in hypopituitary androgen-deficient women: a placebo-controlled trial.
    Johannsson G, Burman P, Wirén L, Engström BE, Nilsson AG, Ottosson M, Jonsson B, Bengtsson BA, Karlsson FA.
    J Clin Endocrinol Metab; 2002 May; 87(5):2046-52. PubMed ID: 11994339
    [Abstract] [Full Text] [Related]

  • 24. Metabolic and hormonal effects of oral DHEA in premenopausal women with HIV infection: a randomized, prospective, placebo-controlled pilot study.
    Poretsky L, Song L, Brillon DJ, Ferrando S, Chiu J, McElhiney M, Ferenczi A, Sison C, Haller I, Rabkin J.
    Horm Metab Res; 2009 Mar; 41(3):244-9. PubMed ID: 18810712
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Endocrine effects of oral dehydroepiandrosterone in men with HIV infection: a prospective, randomized, double-blind, placebo-controlled trial.
    Poretsky L, Brillon DJ, Ferrando S, Chiu J, McElhiney M, Ferenczi A, Sison MC, Haller I, Rabkin J.
    Metabolism; 2006 Jul; 55(7):858-70. PubMed ID: 16784956
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Oral dehydroepiandrosterone (DHEA) replacement therapy in women with Addison's disease.
    Gebre-Medhin G, Husebye ES, Mallmin H, Helström L, Berne C, Karlsson FA, Kämpe O.
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):775-80. PubMed ID: 10848883
    [Abstract] [Full Text] [Related]

  • 29. Oral dehydroepiandrosterone for adrenal androgen replacement: pharmacokinetics and peripheral conversion to androgens and estrogens in young healthy females after dexamethasone suppression.
    Arlt W, Justl HG, Callies F, Reincke M, Hübler D, Oettel M, Ernst M, Schulte HM, Allolio B.
    J Clin Endocrinol Metab; 1998 Jun; 83(6):1928-34. PubMed ID: 9626121
    [Abstract] [Full Text] [Related]

  • 30. Effects of a two-week physiological dehydroepiandrosterone substitution on cognitive performance and well-being in healthy elderly women and men.
    Wolf OT, Neumann O, Hellhammer DH, Geiben AC, Strasburger CJ, Dressendörfer RA, Pirke KM, Kirschbaum C.
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2363-7. PubMed ID: 9215320
    [Abstract] [Full Text] [Related]

  • 31. Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial.
    Blackman MR, Sorkin JD, Münzer T, Bellantoni MF, Busby-Whitehead J, Stevens TE, Jayme J, O'Connor KG, Christmas C, Tobin JD, Stewart KJ, Cottrell E, St Clair C, Pabst KM, Harman SM.
    JAMA; 2002 Nov 13; 288(18):2282-92. PubMed ID: 12425705
    [Abstract] [Full Text] [Related]

  • 32. DHEA in elderly women and DHEA or testosterone in elderly men.
    Nair KS, Rizza RA, O'Brien P, Dhatariya K, Short KR, Nehra A, Vittone JL, Klee GG, Basu A, Basu R, Cobelli C, Toffolo G, Dalla Man C, Tindall DJ, Melton LJ, Smith GE, Khosla S, Jensen MD.
    N Engl J Med; 2006 Oct 19; 355(16):1647-59. PubMed ID: 17050889
    [Abstract] [Full Text] [Related]

  • 33. Growth hormone substitution in adult growth hormone-deficient men augments androgen effects on the skin.
    Blok GJ, de Boer H, Gooren LJ, van der Veen EA.
    Clin Endocrinol (Oxf); 1997 Jul 19; 47(1):29-36. PubMed ID: 9302369
    [Abstract] [Full Text] [Related]

  • 34. The effect of growth hormone replacement therapy on adrenal androgen secretion in adult onset hypopituitarism.
    Isidori AM, Kaltsas GA, Perry L, Burrin JM, Besser GM, Monson JP.
    Clin Endocrinol (Oxf); 2003 May 19; 58(5):601-11. PubMed ID: 12699442
    [Abstract] [Full Text] [Related]

  • 35. Panhypopituitarism as a model to study the metabolism of dehydroepiandrosterone (DHEA) in humans.
    Young J, Couzinet B, Nahoul K, Brailly S, Chanson P, Baulieu EE, Schaison G.
    J Clin Endocrinol Metab; 1997 Aug 19; 82(8):2578-85. PubMed ID: 9253337
    [Abstract] [Full Text] [Related]

  • 36. Effects of single nightly injections of growth hormone-releasing hormone (GHRH 1-29) in healthy elderly men.
    Vittone J, Blackman MR, Busby-Whitehead J, Tsiao C, Stewart KJ, Tobin J, Stevens T, Bellantoni MF, Rogers MA, Baumann G, Roth J, Harman SM, Spencer RG.
    Metabolism; 1997 Jan 19; 46(1):89-96. PubMed ID: 9005976
    [Abstract] [Full Text] [Related]

  • 37. Plasma adrenal, gonadal, and conjugated steroids before and after long-term overfeeding in identical twins.
    Pritchard J, Després JP, Gagnon J, Tchernof A, Nadeau A, Tremblay A, Bouchard C.
    J Clin Endocrinol Metab; 1998 Sep 19; 83(9):3277-84. PubMed ID: 9745441
    [Abstract] [Full Text] [Related]

  • 38. Dehydroepiandrosterone secretion in healthy older men and women: effects of testosterone and growth hormone administration in older men.
    Muniyappa R, Wong KA, Baldwin HL, Sorkin JD, Johnson ML, Bhasin S, Harman SM, Blackman MR.
    J Clin Endocrinol Metab; 2006 Nov 19; 91(11):4445-52. PubMed ID: 16926252
    [Abstract] [Full Text] [Related]

  • 39. Restoring testosterone levels by adding dehydroepiandrosterone to a drospirenone containing combined oral contraceptive: I. Endocrine effects.
    Zimmerman Y, Foidart JM, Pintiaux A, Minon JM, Fauser BC, Cobey K, Coelingh Bennink HJ.
    Contraception; 2015 Feb 19; 91(2):127-33. PubMed ID: 25604900
    [Abstract] [Full Text] [Related]

  • 40. Five-day pulsatile gonadotropin-releasing hormone administration unveils combined hypothalamic-pituitary-gonadal defects underlying profound hypoandrogenism in men with prolonged critical illness.
    van den Berghe G, Weekers F, Baxter RC, Wouters P, Iranmanesh A, Bouillon R, Veldhuis JD.
    J Clin Endocrinol Metab; 2001 Jul 19; 86(7):3217-26. PubMed ID: 11443192
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 79.